The activation domain of simian immunodeficiency virus SIVmac239 Rev protein is structurally and functionally analogous to the HIV-1 Rev activation domain

Virology. 1995 Aug 1;211(1):285-9. doi: 10.1006/viro.1995.1403.

Abstract

The Rev proteins of primate immunodeficiency viruses are essential transactivators for the switch from early to late phase in the viral replication cycle. By mutational analysis, a putative activation domain (AD) has been assigned to the carboxy-terminus. This leucine-rich stretch of amino acids proved to be essential for the transactivating properties of HIV-1 Rev. Some mutants in the AD transdominantly inhibit the function of wild-type Rev protein very efficiently. We identified a similar domain structure for SIVmac239 Rev by sequence comparison and in vitro mutagenesis. The leucine/isoleucine residues of the SIVmac239 Rev activation domain appeared to be of similar importance for function. The mutants of these residues in the SIV AD displayed a dominant negative phenotype on both HIV-1 and SIVmac 239 rev-responsive elements (RRE). The prokaryotically expressed wild-type and mutant proteins were analyzed for RNA-binding properties in a gel-shift assay in vitro. This assay revealed a similar binding pattern of wild-type and transdominant proteins on either RRE.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Binding Sites
  • Conserved Sequence
  • DNA Mutational Analysis
  • Gene Products, rev / biosynthesis
  • Gene Products, rev / chemistry
  • Gene Products, rev / metabolism*
  • HIV-1 / physiology*
  • Leucine
  • Molecular Sequence Data
  • Mutagenesis, Insertional
  • Point Mutation
  • Sequence Homology, Amino Acid
  • Simian Immunodeficiency Virus / physiology*
  • Virus Activation*
  • Virus Replication*
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, rev
  • rev Gene Products, Human Immunodeficiency Virus
  • Leucine